Skin Reactions Secondary to Anticancer Agents - European Medical Journal

Continue

Skin Reactions Secondary to Anticancer Agents

Dermatology
Download PDF
Authors:
Gabriella Fabbrocini,1 Rosanna Izzo,2 Luigia Panariello,3 Giuseppe Monfrecola4

1. Associate Professor, Venereal and Cutaneous Diseases, Division of Dermatology and Venereology, Department of Clinical Medicine and Surgery, University of Naples ‘Federico II’, Italy
2. Doctor, Department of Clinical Medicine and Surgery, University of Naples ‘Federico II’, Italy
3. Specialist, Clinical Dermatology, University of Naples ‘Federico II’, Italy
4. Professor, Venereal and Cutaneous Diseases, Division of Dermatology and Venereology, Department of Clinical Medicine and Surgery, University of Naples ‘Federico II’, Italy

Disclosure:

No potential conflict of interest.

Received:
17.09.13
Accepted:
11.11.13
Citation:
EMJ Dermatol. ;1[1]:38-43. DOI/10.33590/emjdermatol/10313525. https://doi.org/10.33590/emjdermatol/10313525.
Keywords:
Skin reaction, chemotherapy, EGF-R inhibitors, radiodermatitis

Each article is made available under the terms of the Creative Commons Attribution-Non Commercial 4.0 License.

Abstract

In recent decades, new chemotherapeutic agents have been introduced in cancer therapy. The skin is often the target for the toxicity of these drugs. Skin side-effects may decrease the compliance and the quality of life of these patients. To cure and to prevent these side-effects dermatologists can cooperate with oncologists. In this paper we propose a brief review of the main toxic skin events caused by chemotherapeutic agents, in particular linked to the epidermal growth factor receptor (EGF-R) inhibitor.

Please view the full content in the PDF above.

Rate this content's potential impact on patient outcomes

Average rating / 5. Vote count:

No votes so far! Be the first to rate this content.

Thank you!

Please share some more information on the rating you have given